Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Non Operating Interest Expenses (2010 - 2023)

Updated

Lexicon Pharmaceuticals (LXRX) posted Non Operating Interest Expenses of $3.9 million for Q3 2023, up 351.3% from $864,000 a year earlier and up 98.9% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Non Operating Interest Expenses (2010 - 2023) Analysis & Trends

For the trailing twelve months through Sep 30, 2023, Non Operating Interest Expenses at Lexicon Pharmaceuticals was $8.78 million, up 345.4% year-over-year; for FY2022, it came in at $2.78 million, up 246.6% from FY2021.

  • Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -16.8% (FY2017 to FY2022).
  • In prior years, Lexicon Pharmaceuticals' Non Operating Interest Expenses was $802,000 in FY2021 (-94.5%), $14.54 million in FY2020 (-29.7%), $20.68 million in FY2019 (-0.5%) and $20.78 million in FY2018 (+197.5%).
  • The Q3 2023 figure stands as the highest quarterly Non Operating Interest Expenses since Q3 2020.
  • On a year-over-year basis, Non Operating Interest Expenses increased in six of the last seven quarters, with growth averaging 223.5%.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2022, with growth of 405.3%; the weakest was Q1 2021, with a decline of 96.7%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.96 million (Q2 2023), $1.82 million (Q1 2023) and $1.1 million (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Lexicon Pharmaceuticals 813.30 Mn 239.86 Mn 653,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.90 Mn
Jun 30, 2023 1.96 Mn
Mar 31, 2023 1.82 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 864,000.00
Jun 30, 2022 703,000.00
Mar 31, 2022 110,000.00
Dec 31, 2021 295,000.00
Sep 30, 2021 171,000.00
Jun 30, 2021 169,000.00
Mar 31, 2021 167,000.00
Dec 31, 2020 170,000.00
Sep 30, 2020 4.12 Mn
Jun 30, 2020 5.13 Mn
Mar 31, 2020 5.13 Mn
Dec 31, 2019 5.19 Mn
Sep 30, 2019 5.20 Mn
Jun 30, 2019 5.16 Mn
Mar 31, 2019 5.12 Mn
Dec 31, 2018 5.23 Mn
API Access

Lexicon Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LXRX&period=max&api_key=YOUR_API_KEY